BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10498405)

  • 1. Correspondence re: C. Chen et al., CYP2D6 genotype and the incidence of anal and vulvar cancer. Cancer Epidemiol. Biomark. Prev., 8: 317-321, 1999.
    Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):839-40. PubMed ID: 10498405
    [No Abstract]   [Full Text] [Related]  

  • 2. CYP2D6 genotype and the incidence of anal and vulvar cancer.
    Chen C; Cook LS; Li XY; Hallagan S; Madeleine MM; Daling JR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):317-21. PubMed ID: 10207635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CYP2D6 activity and tobacco on larynx cancer risk.
    Benhamou S; Bouchardy C; Paoletti C; Dayer P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):683-6. PubMed ID: 8877058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correspondence re: Weiderpass et al., Alcoholism and risk of cancer of cervix uteri, vagina, and vulva. Cancer Epidemiol. Biomark. Prev., 10: 899-901, 2001.
    Chiaffarino F; Gallus S; Negri E; Parazzini F; Franceschi S; La Vecchia C
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):325-6. PubMed ID: 11895888
    [No Abstract]   [Full Text] [Related]  

  • 5. Correspondence re: Czene et al., Analysis of DNA and hemoglobin adducts and sister chromatid exchanges in a human population occupationally exposed to propylene oxide: a pilot study. Cancer Epidemiol. Biomark. Prev., 11: 315-318, 2002.
    Albertini RJ
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):388; author reply 388-9. PubMed ID: 12692119
    [No Abstract]   [Full Text] [Related]  

  • 6. Anal human papillomavirus infection and squamous neoplasia in patients with invasive vulvar cancer.
    Ogunbiyi OA; Scholefield JH; Robertson G; Smith JH; Sharp F; Rogers K
    Obstet Gynecol; 1994 Feb; 83(2):212-6. PubMed ID: 8290182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco-specific nitrosamines.
    Spiegelhalder B; Bartsch H
    Eur J Cancer Prev; 1996 Sep; 5 Suppl 1():33-8. PubMed ID: 8972290
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic activation and detoxification of tobacco-specific nitrosamines--a model for cancer prevention strategies.
    Hecht SS
    Drug Metab Rev; 1994; 26(1-2):373-90. PubMed ID: 8082576
    [No Abstract]   [Full Text] [Related]  

  • 9. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus.
    Jamieson DJ; Paramsothy P; Cu-Uvin S; Duerr A;
    Obstet Gynecol; 2006 May; 107(5):1023-8. PubMed ID: 16648406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correspondence re: C. Byrne et al., Predictors of dietary heterocyclic amine intake in three prospective cohorts. Cancer Epidemiol. Biomark. Prev., 7: 523-529, 1998.
    Tannenbaum SR
    Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1153-4. PubMed ID: 9865435
    [No Abstract]   [Full Text] [Related]  

  • 11. Correspondence re: H. J. Lin et al., Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol., Biomark, Prev., 7: 647-652, 1998.
    Acquavella J; Cullen MR
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):947-9. PubMed ID: 10548326
    [No Abstract]   [Full Text] [Related]  

  • 12. CYP2D6 genotype and smoking behaviour in cigarette smokers.
    Boustead C; Taber H; Idle JR; Cholerton S
    Pharmacogenetics; 1997 Oct; 7(5):411-4. PubMed ID: 9352579
    [No Abstract]   [Full Text] [Related]  

  • 13. Smokeless tobacco and oral cancer.
    Badovinac R; Hayes C; Monopoli M
    J Mass Dent Soc; 2001; 50(1):26-9, 47. PubMed ID: 11326709
    [No Abstract]   [Full Text] [Related]  

  • 14. Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users.
    Nair J; Ohshima H; Nair UJ; Bartsch H
    Crit Rev Toxicol; 1996; 26(2):149-61. PubMed ID: 8688158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco-specific nitrosamines.
    Hecht SS; Peterson LA; Spratt TE
    IARC Sci Publ; 1994; (125):91-106. PubMed ID: 7806343
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions.
    Hoffmann D; Hecht SS
    Cancer Res; 1985 Mar; 45(3):935-44. PubMed ID: 3882226
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
    Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 CYP2D6.
    Wolf CR; Smith G
    IARC Sci Publ; 1999; (148):209-29. PubMed ID: 10493260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between cytochrome P450 2D6 and lung cancer susceptibility caused by smoking].
    Yan Z; Wu Y; Wu Y
    Wei Sheng Yan Jiu; 2007 Jan; 36(1):112-3, 116. PubMed ID: 17424863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
    Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
    Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.